Michal Abrahamowicz
Research Scientist, PhD
Appointments
- James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
- Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre
Research Interests
- Biostatistics
- Survival analysis
- Pharmacoepidemiology
- Clinical epidemiology
- Epidemiologic methods
- Longitudinal analysis
- Non-communicable disease epidemiology
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.
His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).Learn more
Recent News Coverage
ARThritis Soirée returns to The Roof on May 21, 2020!
ARThritis Soirée returns to The Roof on May 21, 2020! Bill Henderson of Chilliwack set to perform in support of arthritis research Arthritis Research Canada’s signature event, the ARThritis Soirée, will celebrate its eighth year of raising awareness and funds for...
Linda Li Announced as a Fellow of the Canadian Academy of Health Sciences
Linda Li Announced as a Fellow of the Canadian Academy of Health Sciences Vancouver, BC – Congratulations to Arthritis Research Canada’s Senior Research Scientist, Dr. Linda Li - who was announced as a Fellow of the Canadian Academy of Health Sciences....
Gout Patients at Higher Risk of Developing Life-Threatening Blood Clot
Gout Patients at Higher Risk of Developing Life-Threatening Blood Clot An Arthritis Research Canada study has revealed that people with gout (the most common inflammatory arthritis in men) are more likely to develop venous thromboembolism (VTE) – a blood...
How Common are Mental Health Problems in Arthritis Patients?
How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem A recent Arthritis Research Canada study has revealed that while administrative health databases are increasingly being used to study...
Olympic snowboarder joins team Arthritis Research Canada
Olympic snowboarder joins team Arthritis Research Canada Arthritis Research Canada is excited to announce Team Canada’s Spencer O’Brien as its official spokesperson. O’Brien was diagnosed with rheumatoid arthritis – a serious autoimmune disease whereby the...
September is Arthritis Awareness Month
September is Arthritis Awareness Month Arthritis Research Canada has launched a month-long campaign to create awareness about the most costly chronic disease in this country: arthritis. There are over 100 different forms of arthritis. It impacts six...
I’m Spencer O’Brien, Ask Me Anything
I'm Spencer O'Brien, Ask Me Anything Do you have questions about what it’s like to live with rheumatoid arthritis at a young age? Would you like a Team Canada Olympic snowboarder with RA to answer your questions? Our Reddit AMA with Spencer O'Brien is now...
Research reveals potential care gap for pregnant women with lupus
Research reveals potential care gap for pregnant women with lupus A new study by Arthritis Research Canada has found that almost 30 per cent of pregnant women with systemic lupus erythematosus discontinue their antimalarials (especially in the first...
What you need to know about biosimilars
What you need to know about biosimilars On May 27, British Columbia became the first province to expand the use of biosimilars/biogenerics. Find out what this means for the more than 800,000 people in BC living with arthritis.To read our frequently asked...
Arthritis Research Canada opens fourth centre
Arthritis Research Canada opens fourth centre Arthritis Research Canada, the largest clinical arthritis research institution in North America, continues to grow with its newest centre located at McGill University. Drs. Deborah Da Costa, Michal...
